Duchenne muscular dystrophy (DMD) is a severe degenerative muscle disease caused by mutations in the…
kchenFebruary 23, 2021
New funding: Notch Therapeutics has raised a $85 million Series A round, bringing its total funding to…
kchenFebruary 22, 2021
Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.,…
emcguinnFebruary 18, 2021
In the race for a COVID-19 vaccine, messenger RNA (mRNA) vaccines finished first. This includes…
emcguinnFebruary 17, 2021
Seagen Inc. (Nasdaq:SGEN) today announced that the European Commission (EC) has granted marketing authorization for…
emcguinnFebruary 17, 2021
New funding: Ozette, a biotech company that last year spun out of the Fred Hutchinson Cancer Research…
emcguinnFebruary 17, 2021
Boston-based biotech startup Ensoma launched Thursday and announced a $70 million Series A funding round. The company…
emcguinnFebruary 16, 2021
Just like us, immune cells need fuel to do their jobs. Despite the tight links between human health — including…
emcguinnFebruary 15, 2021
Today’s Food and Drug Administration approval of Bristol Myers Squibb’s liso-cel for the treatment of…
emcguinnFebruary 12, 2021
